Fundraising Fox

Hemanta Baruah

InvestorFounder

Founder / EIR at 82VS · Founder & CEO at Aakha

Dallas-Fort Worth Metroplex

FoundedAakha

Find your path to Hemanta

369 people in our graph share verified history with Hemanta — schools, employers, funds. One of them is your warm intro.

Noubar AfeyanunlockedHemanta: together at MIT (2005–2009)
×3Hemanta: together at MIT
×7Hemanta: together at Wake Forest University
Hemanta: together at Adimab

About

Hemanta Baruah is founder and CEO of Aakha Biologics. He brings over 15 years of experience in antibody discovery, protein engineering, and protein sciences across industry and academic settings, and serves as lead inventor of the approved therapeutic Sintilimab, an anti-PD-1 antibody. He has managed multiple monoclonal and bispecific antibody discovery programs across disease areas currently in advanced clinical development.

Founder & CEO at Aakha

Intro paths

In turn, Hemanta can intro founders to Aakha's investors below.

Aakha's investors · 1

Experience

  1. Aakha BiologicsFounder & CEO of Aakha Biologicscurrent2021 — presentDallas-Fort Worth Metroplex
  2. Alloy Therapeutics, Inc.Entrepreneur In Residence2020 — 2021Lexington, Massachusetts, United States
  3. Dragonfly Therapeutics, Inc.Associate Director of Protein Engineering2018 — 2020Greater Boston
  4. Abexxa Biologics, Inc.Principal Scientist2016 — 2018Dallas-Fort Worth Metroplex
  5. Adimab, LLCSenior Scientist2016Lebanon NH
  6. Adimab, LLCScientist II in Antibody engineering2011 — 2015Lebanon
  7. Adimab, LLCScientist I in protein Analytics and Antibody Engineering2009 — 2011
  8. MITPostdoctoral Research Associate under Prof. Alice Y. Ting2005 — 2009
  9. Wake Forest UniversityPhD Student under Prof. Ulrich Bierbach2000 — 2004

Skills & more

Antibodies35Protein Chemistry31Cell2Cell Biology8DNA2ELISA7Molecular Biology3Monoclonal Antibodies5NMR2Purification8recombinant DNA technology3SDS-PAGE14

From Hemanta's professional profile.

Colleagues at 82VS

Frequently asked questions

Who is Hemanta Baruah?
Hemanta Baruah is founder and CEO of Aakha Biologics. He brings over 15 years of experience in antibody discovery, protein engineering, and protein sciences across industry and academic settings, and serves as lead inventor of the approved therapeutic Sintilimab, an anti-PD-1 antibody. He has managed multiple monoclonal and bispecific antibody discovery programs across disease areas currently in advanced clinical development.
Where does Hemanta Baruah work?
Hemanta Baruah is Founder & CEO of Aakha and Founder / EIR at 82VS.
What companies did Hemanta Baruah found?
Hemanta Baruah founded Aakha.
Where did Hemanta Baruah go to school?
Hemanta Baruah studied at Massachusetts Institute of Technology (Post doc, Biological Science and Protein Engineering); Wake Forest University (PhD, chemistry); Indian Institute of Technology, Kharagpur (M.Sc, Chemistry).

Founder mafias

Massachusetts Institute of Technology mafia1,220

Also came through, then founded or led a company.

+ 1,213 more

Indian Institute of Technology, Kharagpur mafia141

Also came through, then founded or led a company.

+ 134 more

Wake Forest University mafia27

Also came through, then founded or led a company.

+ 20 more

82VS mafia8

Also came through, then founded or led a company.

+ 1 more

Adimab mafia2

Also came through, then founded or led a company.

Same school

Shared employers